§ 12-15-35-51 — Advisory committee; duties; report

(a) As used in this section, "advisory
committee" refers to the mental health Medicaid quality advisory
committee established by subsection (b).
(b) The mental health Medicaid quality advisory committee is
established. The advisory committee consists of the following
members:
(1) The director of the office or the director's designee, who shall
serve as chairperson of the advisory committee.
(2) The director of the division of mental health and addiction or
the director's designee.
(3) A representative of a statewide mental health advocacy
organization.
(4) A representative of a statewide mental health provider
organization.
(5) A representative from a managed care organization that
participates in the state's Medicaid program.
(6) A member with expertise in psychiatric research representing
an academic institution.
(7) A pharmacist licensed under IC 25-26.
(8) The commissioner of the department of correction or the
commissioner's designee.
The governor shall make the appointments for a term of four (4) years
under subdivisions (3) through (7) and fill any vacancy on the advisory
committee.
(c) The office shall staff the advisory committee. The expenses of
the advisory committee shall be paid by the office.
(d) Each member of the advisory committee who is not a state
employee is entitled to the minimum salary per diem provided by IC 4-10-11-2.1(b). The member is also entitled to reimbursement for
traveling expenses as provided under IC 4-13-1-4 and other expenses
actually incurred in connection with the member's duties as provided
in the state policies and procedures established by the Indiana
department of administration and approved by the budget agency.
(e) Each member of the advisory committee who is a state employee
is entitled to reimbursement for traveling expenses as provided under
IC 4-13-1-4 and other expenses actually incurred in connection with
the member's duties as provided in the state policies and procedures
established by the Indiana department of administration and approved
by the budget agency.
(f) The affirmative votes of a majority of the voting members
appointed to the advisory committee are required by the advisory
committee to take action on any measure.
(g) The advisory committee shall advise the office and make
recommendations concerning the clinical use of mental health and
addiction medications and consider the following:
(1) Peer reviewed medical literature.
(2) Observational studies.
(3) Health economic studies.
(4) Input from physicians and patients.
(5) Any other information determined by the advisory committee
to be appropriate.
(h) The office shall report recommendations made by the advisory
committee to the drug utilization review board established by section
19 of this chapter.
(i) The advisory committee shall select one (1) member of the
advisory committee to serve as representation on the therapeutics
committee established by section 20.5 of this chapter.

Legislative History

As added by P.L.36-2009, SEC.2. Amended by P.L.185-2013, SEC.1; P.L.205-2013, SEC.207; P.L.2-2014, SEC.65; P.L.53-2014, SEC.107; P.L.130-2018, SEC.50; P.L.213-2025, SEC.115.